Literature DB >> 6183207

Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum.

K Oguma, T Agui, B Syuto, K Kimura, H Iida, S Kubo.   

Abstract

Monoclonal antibodies against type C1 toxin produced by Clostridium botulinum type C strain Stockholm (C-ST) were prepared by fusion of BALB/c myeloma cells P3X63-Ag8, with spleen cells from the mice immunized by C-ST toxoid. About 5% of single-cell colonies in wells were found to produce antibodies against the toxin as determined by an enzyme-linked immunosorbent assay (ELISA). Four different hybridoma cell lines, no. 9, 12, 14, and 17, were established, cloned by limiting dilution, and intraperitoneally injected into mice to obtain the ascites fluids containing high-titered antibodies. The reactions of these antibodies to type C1 and D toxins of strains C-ST, D-1873, and D-South African (D-SA) were observed by both neutralization and ELISA tests. Three monoclonal antibodies, no. 9, 14, and 17, reacted with C-ST toxin, but only no. 17 highly neutralized the toxin. These antibodies did not react with type D toxins. On the contrary, no. 12 reacted with toxins of both C-ST and D-SA (but not of D-1873) and commonly neutralized these two toxins. This indicates that there is a common antigenic part between C-ST and D-SA toxin molecules which participates in the toxin-neutralizing reaction. The neutralization profiles of C-ST toxin by no. 12 and 17 antibodies were different in a time-to-death test of mice. The mechanisms of neutralization by no. 12 and 17 may be different.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183207      PMCID: PMC347689          DOI: 10.1128/iai.38.1.14-20.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  7 in total

1.  The use of Coomassie Brilliant Blue G250 perchloric acid solution for staining in electrophoresis and isoelectric focusing on polyacrylamide gels.

Authors:  A H Reisner; P Nemes; C Bucholtz
Journal:  Anal Biochem       Date:  1975-04       Impact factor: 3.365

2.  Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum.

Authors:  D A Boroff; U Fleck
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

3.  Isoelectric focusing in polyacrylamide gels.

Authors:  P Righetti; J W Drysdale
Journal:  Biochim Biophys Acta       Date:  1971-04-27

4.  Isolation and molecular size of Clostridium botulinum type C toxin.

Authors:  B Syuto; S Kubo
Journal:  Appl Environ Microbiol       Date:  1977-02       Impact factor: 4.792

5.  Antigenicity of converting phages obtained from Clostridium botulinum types C and D.

Authors:  K Oguma; H Iida; M Shiozaki; K Inoue
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

6.  Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.

Authors:  K Oguma; B Syuto; T Agui; H Iida; S Kubo
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

7.  Separation and characterization of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution.

Authors:  B Syuto; S Kubo
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

  7 in total
  11 in total

1.  Molecular diversity of neurotoxins from Clostridium botulinum type D strains.

Authors:  K Moriishi; B Syuto; S Kubo; K Oguma
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Monoclonal antibody to type F Clostridium botulinum toxin.

Authors:  J L Ferreira; M K Hamdy; S G McCay; F A Zapatka
Journal:  Appl Environ Microbiol       Date:  1990-03       Impact factor: 4.792

3.  Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin.

Authors:  K Tsuzuki; N Yokosawa; B Syuto; I Ohishi; N Fujii; K Kimura; K Oguma
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

4.  Biochemical classification of Clostridium botulinum type C and D strains and their nontoxigenic derivatives.

Authors:  K Oguma; T Yamaguchi; K Sudou; N Yokosawa; Y Fujikawa
Journal:  Appl Environ Microbiol       Date:  1986-02       Impact factor: 4.792

5.  Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813.

Authors:  J Terajima; B Syuto; J O Ochanda; S Kubo
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

6.  Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.

Authors:  J O Ochanda; B Syuto; K Oguma; H Iida; S Kubo
Journal:  Appl Environ Microbiol       Date:  1984-06       Impact factor: 4.792

7.  Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies.

Authors:  K Oguma; S Murayama; B Syuto; H Iida; S Kubo
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

8.  Binding of Clostridium botulinum type C neurotoxin to different neuroblastoma cell lines.

Authors:  N Yokosawa; Y Kurokawa; K Tsuzuki; B Syuto; N Fujii; K Kimura; K Oguma
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

Review 9.  Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum.

Authors:  Laura M Zarebski; Kerrie Vaughan; John Sidney; Bjoern Peters; Howard Grey; Kim D Janda; Arturo Casadevall; Alessandro Sette
Journal:  Expert Rev Vaccines       Date:  2008-02       Impact factor: 5.217

Review 10.  Monoclonal antibodies and toxins--a perspective on function and isotype.

Authors:  Siu-Kei Chow; Arturo Casadevall
Journal:  Toxins (Basel)       Date:  2012-06-11       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.